Cancer cases among Indian men are on the rise, driven largely by tobacco use, air pollution, and lifestyle factors, with oral ...

As of September 30, 2025, Corvus had cash, cash equivalents and marketable securities of $65.7 million as compared to $52.0 million as of December 31, 2024. Consistent with last quarter, Corvus ...

South Rampart Pharma is working to develop an oral small molecule non-opioid pain treatment which has generated early positive clinical data as a therapy for acute and chronic pain, as well as ...

The first sickle cell disease patient has been enrolled in a Phase 1b trial testing iadademstat, Oryzon Genomics' ...

Oral makeovers have become increasingly popular over the years, but do they pose any health risks? Gayle Guyardo, host of ...

Without such a framework, the language risks continued fragmentation, inconsistent development, and limited functionality in ...

A new announcement from Crown Bank Dental Congleton confirms that the practice is now accepting bookings for private patient ...

Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") announced that clinical data on rusfertide in polycythemia ...

Recent headlines about acetaminophen use during pregnancy have left many expectant families feeling anxious, but experts say ...

MHRA response is based on the Phase 3 DRAGON interim analysis results Topline final data expected in Q4 2025SAN DIEGO, Nov. 02, 2025 (GLOBE ...

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to DPTX3186, an investigational therapy being ...